Another private messaging app is banned in China. The U.S.-based app Signal encrypts users’ conversations.
American drugmaker Pfizer reveals plans to stop producing biosimilar products in China.
China Bans Messaging App Signal; Pfizer to Halt Biosimilar Drug Production in China
By NTD Newsroom
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.